kroller
neapharma s.rl. - ketorolac - ketorolac
mekinist
novartis europharm limited - trametinib - melanoma - agenti antineoplastici - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 e 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. non a piccole cellule del polmone (nsclc)trametinib in combinazione con dabrafenib è indicato per il trattamento di pazienti adulti con avanzato non a piccole cellule cancro ai polmoni con una braf v600 mutazione.
febrifugam
fatro s.p.a. - paracetamolo - paracetamolo - 200 mg/ml - paracetamol
harmonet 21cpr 0,075mg 0,02mg
medifarm srl - etinilestradiolo/gestodene - compresse rivestite - "0,075 mg + 0,02 mg compresse rivestite" 21 compresse - gestodene ed estrogeno - contraccettivi ormonali sistemici
carbamazepina eg
eg s.p.a. - carbamazepina - carbamazepina
harmonet
medifarm s.r.l. - gestodene ed estrogeno - gestodene ed estrogeno
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
treprostinil orpha 1 mg/ml soluzione per infusione
orpha swiss gmbh - treprostinilum - soluzione per infusione - treprostinilum 1 mg ut treprostinilum natricum, natrii citras dihydricus, natrii chloridum, acidum hydrochloridum concentratum, natrii hydroxidum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.68 mg. - primäre und sekundäre pulmonale hypertonie; chronisch thromboembolische pulmonale hypertonie (cteph) - synthetika
treprostinil orpha 2.5 mg/ml soluzione per infusione
orpha swiss gmbh - treprostinilum - soluzione per infusione - treprostinilum 2.5 mg ut treprostinilum natricum, natrii citras dihydricus, natrii chloridum, acidum hydrochloridum concentratum, natrii hydroxidum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.73 mg. - primäre und sekundäre pulmonale hypertonie; chronisch thromboembolische pulmonale hypertonie (cteph) - synthetika
treprostinil orpha 5 mg/ml soluzione per infusione
orpha swiss gmbh - treprostinilum - soluzione per infusione - treprostinilum 5 mg ut treprostinilum natricum, natrii citras dihydricus, natrii chloridum, acidum hydrochloridum concentratum, natrii hydroxidum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.91 mg. - primäre und sekundäre pulmonale hypertonie; chronisch thromboembolische pulmonale hypertonie (cteph) - synthetika